100000 - Document - Document And Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
100010 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
100020 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
100030 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
100040 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
100050 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
100060 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
100070 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - Company and Nature of Business
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - Revenue
link:presentationLink
link:calculationLink
link:definitionLink
995485 - Disclosure - Balance Sheet Details
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Fair Value Measurements
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Loans
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Leases
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Related Party Transactions
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - Restructuring and Other Charges
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - Stock-Based Compensation
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - Basic and Diluted Net Loss Per Common Share
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - Summary of Significant Accounting Policies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Revenue (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995605 - Disclosure - Balance Sheet Details (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995615 - Disclosure - Fair Value Measurements (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - Loans (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - Leases (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - Related Party Transactions (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - Stock-Based Compensation (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - Basic and Diluted Net Loss Per Common Share (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - Company and Nature of Business - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995695 - Disclosure - Summary of Significant Accounting Policies - Schedule of Percentage of Revenue and Accounts Receivables from Customers (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995705 - Disclosure - Summary of Significant Accounting Policies - Schedule of Percentage of Revenue and Accounts Receivables from Customers (Parenthetical) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - Revenue - Schedule of Revenue Disaggregated by Customer Type (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Revenue - Schedule of Contract Assets and Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - Revenue - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - Revenue - Additional Information (Details 1)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Balance Sheet Details - Schedule of Inventory and Other Deferred Costs (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995765 - Disclosure - Balance Sheet Details - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995775 - Disclosure - Loans - Schedule of Amounts Outstanding (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - Balance Sheet Details - Schedule of Accrued and Other Current Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995795 - Disclosure - Fair Value Measurements - Schedule of Financial Assets Measured at Fair Value on Recurring Basis and Level of Inputs used in such Measurements (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - Fair Value Measurements - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - Fair Value Measurements - Schedule of Risk-free Interest Rate Based on U.S. Treasury Yield Curve Over Expected Term of Warrants (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - Leases - Schedule of Future Minimum Lease Payments (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Fair Value Measurements - Summary of Changes in Fair Value of Level 3 Financial Instruments (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Loans - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Loans - Schedule of Amounts Outstanding (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995865 - Disclosure - Leases - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995875 - Disclosure - Leases - Schedule of Future Minimum Lease Payments (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995885 - Disclosure - Leases - Components of Lease Costs (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995895 - Disclosure - Related Party Transactions - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995905 - Disclosure - Related Party Transactions - Schedule of Amount of Transactions with Tempus (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995915 - Disclosure - Related Party Transactions - Schedule of Amount Due From or To Tempus (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995925 - Disclosure - Restructuring and Other Charges - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995935 - Disclosure - Stock-Based Compensation - Summary of Shares of Common Stock Available for Issuance (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995945 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995955 - Disclosure - Stock-Based Compensation - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995965 - Disclosure - Stock-Based Compensation - Summary of Weighted-average Assumptions Used in Determination of Fair Value of Service-Based Stock Options (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995975 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Unit Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995985 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense by Award Type (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995995 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense by Function (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996005 - Disclosure - Basic and Diluted Net Loss Per Common Share - Schedule of Computation of Basic and Diluted Net Loss per Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
996015 - Disclosure - Basic and Diluted Net Loss Per Common Share - Schedule of Potentially Dilutive Shares Excluded from Computation of Diluted Net Loss per Common Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
Other income (expense), net
Other Nonoperating Income (Expense)
Other Nonoperating Income (Expense) [Member]
Statement [Line Items]
Statement [Line Items]
Transaction Type
Transaction Type [Axis]
Weighted average stock price per share.
Weighted Average Stock Price Per Share
Weighted-average stock price
Accounts receivable
Increase Decrease In Accounts Receivable
Plan Name
Plan Name [Domain]
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Revenue, Remaining Performance Obligation, Amount
Remaining performance obligation, amount
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Entity Incorporation, State or Country Code
Entity Incorporation State Country Code
Restructuring Charges, Total
Restructuring Charges
Restructuring expenses recognized
Restructuring and other charges
Other comprehensive income (loss), net of tax
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Costs and expenses
Costs And Expenses [Abstract]
Loss Contingency [Abstract]
Unrecognized stock-based compensation cost of unvested RSUs
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
Population sequencing.
Population Sequencing [Member]
Population Sequencing
Short-term warrant liability
Warrant Liability Current
Warrant Liability Current
Beginning balance, shares
Ending balance, shares
Shares Outstanding
Other Noncash Income (Expense), Total
Other
Other Noncash Income Expense
Fair Value Hierarchy and NAV
Fair Value By Fair Value Hierarchy Level [Axis]
VA MVP
Veterans Affairs Million Veteran Program [Member]
Veterans affairs million veteran program.
Level 2
Fair Value Inputs Level2 [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
June 2022
Tranche Two [Member]
Tranche two.
Lease expiration month and year.
Lease Expiration Month And Year
Lease expiration month and year
Long-Term Debt, Type
Longterm Debt Type [Domain]
Long-Term Debt, Current Maturities, Total
Less: current portion (included in accrued and other current liabilities)
Long Term Debt Current
2024 (remaining three months)
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
Leases
Lessee Operating Leases [Text Block]
Restructuring Expenses Related to Disposals of Fixed Assets and Impairment of Other Assets
Restructuring Expenses Related to Disposals of Fixed Assets and Impairment of Other Assets
Non-cash charges, disposals of fixed assets and impairment of other assets
Restructuring Cost [Table]
At-Market Equity Offerings.
At-Market Equity Offerings [Policy Text Block]
At-the-Market Equity Offerings
Schedule of the Changes in the Fair Value of the Companies Level 3 Financial Instruments
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
September 2022
Tranche Four [Member]
Tranche four.
Depreciation, Depletion and Amortization, Total
Depreciation and amortization expense
Depreciation and amortization
Depreciation Depletion And Amortization
ArrangementsAndNonarrangementTransactionsMember
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Related Party Transaction [Line Items]
Concentration Risk Benchmark
Concentration Risk By Benchmark [Axis]
Class of Warrant or Right [Axis]
Revenue
Revenue From Contract With Customer [Text Block]
One-time Termination Benefits [Member]
One-time Employee Termination Benefits
Sale of Stock [Domain]
Change during period
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax
Entity Central Index Key
Entity Central Index Key
Warrant liability.
Warrant Liability [Member]
Warrant Liability
Market Development Fees
Proceeds from Fees Received
Common stock, $0.0001 par value - 200,000,000 shares authorized; 70,638,190 and 50,480,694 shares issued and outstanding, respectively
Common Stock Value Outstanding
Changes in operating assets and liabilities
Increase Decrease In Operating Capital [Abstract]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
Cash and cash equivalents, Unrealized Gains
Cash And Cash Equivalents Gross Unrealized Gains
Cash and cash equivalents, gross unrealized gains.
Common stock, shares, issued
Common Stock Shares Issued
Risk-free interest rate, minimum
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
Fair Value Measurement Inputs and Valuation Techniques [Table]
Dividend Yield
Measurement Input, Expected Dividend Rate [Member]
Prepaid expenses and other assets
Increase Decrease In Prepaid Deferred Expense And Other Assets
Income Statement [Abstract]
Entity Address, State or Province
Entity Address, State or Province
Stock Issued During Period, Value, Employee Stock Purchase Plan
Proceeds from ESPP
Lab Equipment Loan
Lab Equipment [Member]
Lab equipment .
Loss before income taxes
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
Richard Chen
Richard Chen [Member]
Richard Chen.
Concentration Risk Type
Concentration Risk Type [Domain]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Contract liability, revenue recognized
Contract With Customer Liability Revenue Recognized
Customer
Major Customers [Axis]
Debt Instrument Redemption Period One [Member]
May 2021
Customer Concentration Risk
Customer
Customer Concentration Risk [Member]
Lease cost
Lease Cost [Abstract]
Liability Class [Axis]
Cover [Abstract]
Summary Of Significant Accounting Policies [Table]
Summary Of Significant Accounting Policies [Table]
Summary of significant accounting policies.
Earnings Per Share, Basic, Total
Net loss per common share-basic
Net loss per share, basic
Earnings Per Share Basic
Operating lease, option to extend
Lessee Operating Lease Option To Extend
Investments, Unrealized Gains
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
Percentage of down payment
Percentage Of Down Payment
Percentage of down payment.
Short-term contract liabilities
Short-term contract liabilities
Short-term contract liabilities
Contract liabilities
Contract With Customer Liability Current
Current Liabilities
Liabilities Current [Member]
Liabilities Current.
Stock-based compensation expense
Allocated Share Based Compensation Expense
Total carrying amount
Long Term Debt
Retained Earnings (Accumulated Deficit), Total
Accumulated deficit
Retained Earnings Accumulated Deficit
Plan Name
Plan Name [Axis]
Performance-based stock option activity, number of shares
Outstanding Options, Number of Shares, Beginning Balance
Outstanding Options, Number of Shares, Ending Balance
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
Current assets
Assets Current [Abstract]
Total common stock reserved for stock awards
Common Stock Capital Shares Reserved For Future Issuance
Net cash used in operating activities
Net Cash Provided By Used In Operating Activities
Unvested Restricted Stock Units, Weighted-Average Grant Date Fair Value, forfeited
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
Options vested and exercisable, Number of Shares
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
Accumulated other comprehensive income (loss)
Accumulated Other Comprehensive Income (Loss), Net of Tax, Total
Accumulated Other Comprehensive Income Loss Net Of Tax
Lease term
Lessee Operating Lease Term Of Contract
Sales [Member]
Property, Plant and Equipment, Net, Total
Property and equipment, net
Property Plant And Equipment Net
2028
Lessee Operating Lease Liability Payments Due Year Four
Long-term contract liabilities (included in other long-term liabilities)
Long-term contract liabilities (included in other long-term liabilities)
Long-term contract liabilities (included in other long-term liabilities)
Contract with Customer, Liability, Noncurrent
Cash flows from operating activities:
Net Cash Provided By Used In Operating Activities [Abstract]
Type of Restructuring [Domain]
Fair Value Measurements Recurring
Fair Value Measurements Recurring [Member]
Restructuring and Related Activities [Abstract]
Schedule of Financial Assets Measured at Fair Value on Recurring Basis and Level of Inputs used in such Measurements
Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block]
Common stock, par value
Common Stock Par Or Stated Value Per Share
Change in unrealized gain on available-for-sale debt securities
Unrealized gain (loss) on available-for-sale debt securities
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
Measurement Input Type [Domain]
Total contract liabilities
Total contract liabilities
Total contract liabilities
Contract liabilities
Contract With Customer Liability
Aaron Tachibana
Aaron Tachibana [Member]
Aaron Tachibana.
Statement Of Cash Flows [Abstract]
2029 and thereafter
Lessee Operating Lease Liability Payments Due After Year Four
Lessee operating lease liability payments due after year four.
Antidilutive Securities, Name
Antidilutive Securities Name [Domain]
Change in fair value-recognized as loss within Other income (expense), net in the consolidated statements of operations
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease), Total
Warrant issued to purchase stock
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Other long-term liabilities
Increase (Decrease) in Other Noncurrent Liabilities
Selling, general, and administrative
Selling General And Administrative Expenses [Member]
Balance Sheet Related Disclosures [Abstract]
Equity Components
Statement Equity Components [Axis]
Entity Address, Address Line One
Entity Address, Address Line One
Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]
Schedule of Computation of Basic and Diluted Net Loss per Share
Employee-related Liabilities, Current, Total
Accrued compensation
Employee Related Liabilities Current
Related Party Transaction [Table]
Unvested Restricted Stock Units, Number of Shares, granted
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
Schedules Of Concentration Of Risk By Risk Factor [Text Block]
Schedule of Percentage of Revenue and Accounts Receivable from Customers
Computer Equipment
Computer Equipment [Member]
Orders and results delivery fees and net promotional fees
Orders and Results Delivery Fees and Net Promotional Fees
Orders and results delivery fees and net promotional fees.
Operating lease liabilities
Increase Decrease In Operating Lease Liabilities
Increase decrease in operating lease liabilities.
Schedule of Potentially Dilutive Shares Excluded from Computation of Diluted Net Loss per Common Share
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]
Risk-free interest rate
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
Outside of United States
Non Us [Member]
At Market Sales Agreement
At Market Sales Agreement [Member]
At-the-Market Sales Agreement.
Unvested Restricted Stock Units, Number of Shares, Beginning Balance
Unvested Restricted Stock Units, Number of Shares, Ending Balance
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
Amendment Flag
Amendment Flag
Long-term operating lease liabilities
Long-term operating lease liabilities
Operating Lease Liability Noncurrent
Additional paid-in capital
Additional Paid In Capital Common Stock
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]
Operating Lease Liability Current Statement Of Financial Position Extensible List
Net loss
Lessee Lease Description [Table]
Lessee Lease Description [Table]
Tempus Warrants
Tempus Warrants [Member]
Tempus warrants.
Outstanding Options, Number of Shares, exercised
Proceeds from exercise of stock options, shares
Stock Issued During Period Shares Stock Options Exercised
Research and development
Research And Development Expense [Member]
Customer
Name Of Major Customer [Domain]
Schedule of Amounts Outstanding
Schedule Of Debt Table [Text Block]
Loans Payable, Current, Total
Loans—current portion (Note 6)
Loans Payable Current
Equity Component
Equity Component [Domain]
Range
Statistical Measurement
Proceeds from Sale of Property, Plant, and Equipment, Total
Proceeds from Sale of Property, Plant, and Equipment
Proceeds from sales of property and equipment
Balance Sheet Details
Supplemental Balance Sheet Disclosures [Text Block]
Interest Expense, Debt, Total
Interest expense
Interest Expense Debt
Other Expense
Other Nonoperating Income (Expense), Total
Other income (expense), net
Other Nonoperating Income Expense
Shares Of Common Stock Reserved For Future Issuance Under E S P P
Shares of common stock reserved for future issuance under ESPP.
Reserved for future ESPP
Disaggregation Of Revenue [Table]
Disaggregation Of Revenue [Table]
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total
Net loss
Profit Loss
Preferred stock, shares issued
Preferred Stock Shares Issued
Changes in foreign currency translation adjustments:
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax [Abstract]
Cash paid for operating lease liabilities
Operating Lease Payments
Proceeds from Stock Options Exercised
Proceeds from exercise of equity awards
Debt Instrument, Unamortized Discount, Total
Less: unamortized discount
Debt Instrument Unamortized Discount
Payables and Accruals [Abstract]
Payables and Accruals [Abstract]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]
Noncash charges related to liability classified Tempus Warrants
Noncash Gain Related To Liability
Noncash gain related to liability.
2011 Plan, 2019 Plan and Inducement Plan
Two Thousand Eleven And Two Thousand Nineteen Equity Incentive Plan And Two Thousand Twenty Inducement Plan [Member]
Two thousand eleven and two thousand nineteen equity incentive plan and two thousand twenty inducement plan.
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Proceeds from ESPP, shares
Reclassified accumulated foreign currency translation adjustment
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Tax
Short-Term Investments, Total
Short-term investments
Short Term Investments
Prepaid expenses and other current assets
Prepaid Expense And Other Assets Current
Options vested and exercisable, Weighted-Average Exercise Price
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
Risk-free interest rate, maximum
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
Type Of Arrangement
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Comprehensive loss
Comprehensive Income Net Of Tax
Common Stock, Shares, Outstanding, Ending Balance
Common Stock, Shares, Outstanding, Beginning Balance
Common stock, shares, outstanding
Common Stock Shares Outstanding
Preferred stock, $0.0001 par value — 10,000,000 shares authorized; none issued
Preferred Stock Value Outstanding
Purchases of available-for-sale debt securities
Payments To Acquire Available For Sale Securities Debt
Preferred stock, par value
Preferred Stock Par Or Stated Value Per Share
Proceeds from maturities of available-for-sale debt securities
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
Revenues
Sales Revenue Net [Member]
Antidilutive Securities
Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]
Entity Interactive Data Current
Entity Interactive Data Current
Restructuring and Related Activities, Completion Date
Restructuring completed date
Costs of revenue
Cost Of Sales [Member]
Document Quarterly Report
Document Quarterly Report
Unvested Restricted Stock Units, Weighted-Average Grant Date Fair Value, vested
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
Related Party Transactions
Related Party Transactions Disclosure [Text Block]
Statement of Financial Position Location, Balance [Axis]
Statistical Measurement
Range [Axis]
Operating lease cost
Operating Lease Cost
Payment of debt
Debt Instrument Periodic Payment Principal
Assets, Fair Value Disclosure, Total
Assets, Fair Value
Assets Fair Value Disclosure
Less: imputed interest
Lessee Operating Lease Liability Discount On Obligation Amount
Lessee operating lease liability discount on obligation amount.
Related and Nonrelated Parties [Domain]
Total lease cost
Lease Cost
Schedule of Revenue Disaggregated by Customer Type
Disaggregation Of Revenue Table [Text Block]
Unvested RSUs
Unvested Restricted Stock Units [Member]
Unvested restricted stock units.
Schedule of Future Minimum Lease Payments
Lessee Operating Lease Liability Maturity Table [Text Block]
Noncash operating lease cost
Noncash Lease Expense
Noncash lease expense.
May 2023
Debt Instrument Redemption Period Three [Member]
Commercial Paper
Commercial Paper [Member]
Reserved for future option and award grants (in shares)
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
Reserved for future award grants
Grant-date fair value per share
Unvested Restricted Stock Units, Weighted-Average Grant Date Fair Value, granted
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
Unrecognized stock-based compensation of unvested options, recognized over weighted-average period
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
Unamortized Market Development Fees
Unamortized Market Development Fees
Unamortized market development fees.
Employee ESPP contributions
Accrued Employee Benefits Current
Fair value determined at settlement as the fair value of per share
Financial Instrument Subject to Mandatory Redemption, Par Value Per Share
Income Statement Location
Statement of Income Location, Balance [Axis]
Total assets
Assets
Expected term (in years)
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
Restructuring Type [Axis]
Natera Inc.
Natera Inc [Member]
Natera Inc.
Commission percentage of sale proceeds from common stock
Commission Percentage Of Sale Proceeds From Common Stock
Commission percentage of sale proceeds from common stock.
Unvested Restricted Stock Units, Number of Shares, vested
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
Recent Accounting Pronouncements
New Accounting Pronouncements Policy Policy [Text Block]
Entity Address, City or Town
Entity Address, City or Town
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income [Member]
Assets
Assets Fair Value Disclosure [Abstract]
Payment of stock issuance costs
Payments of Stock Issuance Costs
Performance-based stock options
Performance-Based Stock Option
Performance Based Stock Option [Member]
Performance-based stock option.
Unvested Restricted Stock Units, Number of Shares, forfeited
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
Short- and long-term Other liabilities
Short and Long Term Other Liabilities [Member]
Short and Long Term Other Liabilities.
Stock Based Compensation Expense by Award Type and Function
Schedule Of Compensation Cost For Share Based Payment Arrangements Allocation Of Share Based Compensation Costs By Plan Table [Text Block]
Principal
Principal amount
Debt Instrument Face Amount
Options vested and exercisable, Weighted-Average Remaining Contractual Term (in years)
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
Restructuring Cost and Reserve [Line Items]
Share price
Share Price
Grant date fair value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value
Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:
Reconciliation Of Cash Cash Equivalents And Restricted Cash [Abstract]
Reconciliation of cash cash equivalents and restricted cash.
Tempus Investment Agreement
Tempus investment agreement.
Stock-Based Compensation
Disclosure Of Compensation Related Costs Share Based Payments [Text Block]
Customer deposits
Contract With Customer Deposits Current
Contract with customer deposits current.
Operating leases, weighted-average discount rate
Operating Lease Weighted Average Discount Rate Percent
Fair Value Disclosures [Abstract]
Outstanding Options, Weighted-Average Exercise Price, forfeited or expired
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
Proceeds from sales of common stock under, net
Stock Issued During Period Value New Issues
Proceeds from exercise of stock options
Stock Issued During Period, Value, Stock Options Exercised
Lessee Lease Description [Line Items]
Lessee Lease Description [Line Items]
Current liabilities
Liabilities Current [Abstract]
Accounts Receivable
Accounts Receivable [Member]
Significant Customers
Significant Customers [Member]
Significant customers.
Document Type
Document Type
U.S. Agency Securities
U S Government Agencies Debt Securities [Member]
Assets, Unrealized Gains
Assets Gross Unrealized Gains
Assets, gross unrealized gains.
Title of 12(b) Security
Security12b Title
Cash and cash equivalents, Adjusted Cost
Cash and cash equivalents
Cash And Cash Equivalents At Carrying Value
Statement of Financial Position Location, Balance [Domain]
Components of Lease Costs
Lease Cost Table [Text Block]
Debt Instrument, Redemption, Period
Debt Instrument Redemption Period [Axis]
Statement Of Stockholders Equity [Abstract]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Ending balance
Beginning balance
Document Fiscal Period Focus
Document Fiscal Period Focus
Research and Development Expense, Total
Research and development
Research And Development Expense
Long-Term Debt, Excluding Current Maturities, Total
Long-term portion (included in other long-term liabilities)
Long Term Debt Noncurrent
Outstanding Options, Number of Shares, granted
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
First Warrant
First Warrant [Member]
First warrant.
Disaggregation Of Revenue [Abstract]
Asset Class
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]
Debt Instrument Redemption Period Two [Member]
May 2022
Summary of Stock Option Activity
Schedule Of Share Based Compensation Activity Table [Text Block]
Tempus
Tempus [Member]
Tempus.
Summary of Weighted-average Assumptions Used in Determination of Fair Value of Stock Options
Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]
September 2024
Tranche Six [Member]
Tranche six.
Unrealized loss position for 12 months or greater on security
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
Warrant exercise price per share
Class of Warrant or Right, Exercise Price of Warrants or Rights
Financial Instruments
Transfers And Servicing Of Financial Instruments Types Of Financial Instruments [Domain]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period
Remaining performance obligation, expected time of satisfaction
Sale of Stock [Axis]
Cash flows from investing activities:
Net Cash Provided By Used In Investing Activities [Abstract]
Total accrued and other current liabilities
Accrued and other current liabilities
Accrued Liabilities And Other Liabilities Current
Accrued liabilities and other liabilities current.
Summary of Restricted Stock Units Activity
Schedule Of Nonvested Restricted Stock Units Activity Table [Text Block]
Revenue
Revenue From Contract With Customer Excluding Assessed Tax
Statement of Comprehensive Income [Abstract]
Statement of Comprehensive Income [Abstract]
Derecognition of warrant liabilities due to exercise in full
Derecognition of warrant liabilities due to exercise
Derecognition of warrant liabilities due to exercise
Selling, General and Administrative Expense, Total
Selling, general and administrative
Selling General And Administrative Expense
Market development fees payable.
Market Development Fees Payable
Market development fees payable
Schedule of Amount of Transactions along with Amounts Due From and To Tempus
Condensed Financial Statements [Table Text Block]
Debt instrument, periodic payment
Debt Instrument, Frequency of Periodic Payment
Increase (Decrease) in Accounts Payable, Total
Accounts payable
Increase Decrease In Accounts Payable
Liabilities and Stockholders’ Equity
Liabilities And Stockholders Equity [Abstract]
Document Period End Date
Document Period End Date
Net cash provided by financing activities
Net Cash Provided By Used In Financing Activities
June 2023
Tranche Three [Member]
Tranche three.
Potentially dilutive securities excluded from computation of diluted net loss per share
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total
Stock-based compensation
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
Accrued Liabilities, Current, Total
Accrued liabilities
Accrued Liabilities Current
Fair market value of promotional and commercialization services
Fair Market Value of Promotional and Commercialization Services
Fair market value of promotional and commercialization services
Significant Accounting Policies
Significant Accounting Policies [Policy Text Block]
Significant accounting policies.
Summary of Shares of Common Stock Reserved for Issuance
Summary Of Shares Of Common Stock Available For Issuance Table [Text Block]
Summary of shares of common stock available for issuance.
Income Tax Expense (Benefit), Total
Provision for income taxes
Income Tax Expense Benefit
Inventory And Other Deferred Costs [Abstract]
Inventory and other deferred costs.
Total inventory and other deferred costs
Inventory and other deferred costs
Inventory And Other Deferred Costs
Inventory and other deferred costs.
Trading Symbol
Trading Symbol
Total stockholders’ equity
Beginning balance
Ending balance
Stockholders Equity
Noncash restructuring and other charges
Noncash Restructuring and Other Charges
Noncash restructuring and other charges.
Tempus Agreement
Tempus Agreement
Tempus Agreement
Long-Lived Tangible Asset
Property Plant And Equipment By Type [Axis]
Other long-term liabilities
Other Liabilities Noncurrent
RSUs
Restricted Stock Units
Restricted Stock Units R S U [Member]
Contract with customer unsatisfied services revenue.
Contract with Customer Unsatisfied Services Revenue
Contract with customer unsatisfied services
Related Party Transactions [Abstract]
Variable lease cost
Variable Lease Cost
Area of office space
Land Subject To Ground Leases
Measurement Input Type [Axis]
Geographical
Statement Geographical [Axis]
Performance-based stock option activity, Fully vested and exercisable intrinsic value
Options vested and exercisable, Aggregate Intrinsic Value
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
Assets, Adjusted Cost
Assets Amortized Cost Basis
Assets, amortized cost basis.
Investments, Unrealized Losses
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
Unrecognized stock-based compensation cost of unvested options
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
Leases [Abstract]
Use of Estimates
Use Of Estimates
Revenue
Concentration risk percentage
Concentration Risk Percentage1
Related Party
Related Party [Member]
Volatility
Measurement Input, Price Volatility [Member]
Volatility, minimum
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
Long-term warrant liability
Warrant Liability Noncurrent
Warrant Liability Noncurrent
Dividend yield
Dividend yield
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
Schedule of Contract Assets and Liabilities
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]
Security Exchange Name
Security Exchange Name
Fair value determined at settlement as the fair value of average exercise price per share
Financial Instrument Subject to Mandatory Redemption, Average Exercise Price Per Share
Financial instrument subject to mandatory redemption, average exercise price per share.
Fair Value by Liability Class [Domain]
Risk-free Interest Rate
Measurement Input, Risk Free Interest Rate [Member]
Long-Lived Tangible Asset
Property Plant And Equipment Type [Domain]
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total
Accumulated depreciation and amortization
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Fair Value Measurements
Fair Value Disclosures [Text Block]
Equipment and Software Loans
Software and Software Development Costs [Member]
2027
Lessee Operating Lease Liability Payments Due Year Three
Weighted-average grant date fair value of options granted
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
Maximum
Maximum [Member]
Restructuring and Related Activities Disclosure [Text Block]
Restructuring and Other Charges
Total liabilities and stockholders’ equity
Liabilities And Stockholders Equity
Operating lease right-of-use assets
Operating Lease Right Of Use Asset
Revenue performance obligation unsatisfied service, period description.
Revenue Performance Obligation Unsatisfied Service, Period Description
Revenue performance obligation unsatisfied service, period
Schedule of Inventory and Other Deferred Costs
Schedule Of Inventory And Other Deferred Costs Table [Text Block]
Schedule of inventory and other deferred costs.
Summary Of Significant Accounting Policies [Line Items]
Summary Of Significant Accounting Policies [Line Items]
Summary of significant accounting policies.
Earnings Per Share, Diluted, Total
Net loss per common share-diluted
Net loss per share, diluted
Earnings Per Share Diluted
Total liabilities
Liabilities
Exercise of Tempus Warrants, Shares
Stock Issued During Period Shares Warrants Exercised
Stock issued during period shares warrants exercised.
Restructuring expenses recognized
Restructuring and Related Cost, Expected Cost
Restructuring and Related Cost, Expected Cost, Total
Fair Value Hierarchy and NAV
Fair Value Measurements Fair Value Hierarchy [Domain]
Total current assets
Assets Current
Payment Agreement with Financing Entity
Payment Agreement With Financing Entity [Member]
Payment agreement with financing entity.
Net cash (used in) provided by investing activities
Net Cash Provided By Used In Investing Activities
Proceeds from sales of common stock, net, shares
Number of shares issued
Stock Issued During Period Shares New Issues
Cash
Cash [Member]
Operating lease, existence of option to extend
Lessee Operating Lease Existence Of Option To Extend
Amortization Of Premium Discount On Short Term Investments
Amortization of premium (discount) on short-term investments.
Amortization of premium (discount) on short-term investments
Entity Filer Category
Entity Filer Category
Unvested Restricted Stock Units, Aggregate Fair Value
Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested
Laboratory Operations and its New Corporate Headquarters
Corporate Headquarters And Laboratory Operations [Member]
Corporate headquarters and laboratory operations.
Total fair value of Tempus Warrants (in thousands)
Equity, Fair Value Disclosure
Equity, Fair Value Disclosure, Total
Debt Instrument, Redemption, Period
Debt Instrument Redemption Period [Domain]
Company and Nature of Business
Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]
Moderna Inc
Moderna, Inc [Member]
Moderna, Inc
2019 Plan and Inducement Plan
Two Thousand Nineteen Equity Incentive Plan And Two Thousand Twenty Inducement Plan [Member]
Two thousand nineteen equity incentive plan and two thousand twenty inducement plan.
Current Fiscal Year End Date
Current Fiscal Year End Date
Imputed interest rate
Debt Instrument Imputed Interest Rate
Debt instrument imputed interest rate.
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Options To Purchase Common Stock
Options To Purchase Common Stock [Member]
Options to purchase common stock.
Share-Based Payment Arrangement, Noncash Expense, Total
Stock-based compensation expense
Share Based Compensation
2019 Employee Stock Purchase Plan
Two Thousand Nineteen Employee Stock Purchase Plan [Member]
Two thousand nineteen employee stock purchase plan.
Outstanding Options, Aggregate Intrinsic Value
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
Related and Nonrelated Parties [Axis]
Inventory and other deferred costs
Increase Decrease In Inventories And Other Deferred Costs
Increase (decrease) in inventories and other deferred costs.
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]
Entity Registrant Name
Entity Registrant Name
Number of reportable segments
Number Of Reportable Segments
Cost of Revenue, Total
Cost of revenue
Cost Of Revenue
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Basic and Diluted Net Loss Per Common Share
Earnings Per Share [Text Block]
Entity Emerging Growth Company
Entity Emerging Growth Company
Transaction
Transaction [Domain]
Money Market Funds
Money Market Funds [Member]
Weighted Average Number of Shares Outstanding, Basic, Total
Weighted-average common shares outstanding-basic
Weighted-average shares outstanding, basic
Weighted Average Number Of Shares Outstanding Basic
Schedule of Accrued and Other Current Liabilities
Accrued Liabilities And Other Liabilities Disclosure Current Table [Text Block]
Accrued liabilities and other liabilities disclosure current.
Restructuring and Related Cost, Number of Positions Eliminated
Number of employees affected in workforce reduction
Stock issuance cost
Stock Issuance Costs
Stock issuance costs.
First milestone fee
First Milestone Fee
First milestone fee.
Volatility, maximum
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
Common stock, shares authorized
Common Stock Shares Authorized
Debt Disclosure [Table]
Debt Disclosure [Table]
Debt disclosure.
Proceeds from sales of common stock under ATM facility, net of commissions
Proceeds from sale of stock
Proceeds from Issuance of Common Stock
Concentration Risk Type
Concentration Risk By Type [Axis]
First milestone payments upon achievement of specified clinical validations
First milestone payments upon achievement of specified clinical validations
Level 1
Fair Value Inputs Level1 [Member]
Restricted Stock Units, Aggregate Fair Value, vested
Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
Noncash loss from remeasurement of warrants
Noncash Income (Loss) from Remeasurement of Warrants
Noncash income (loss) from remeasurement of warrants.
Debt Disclosure [Abstract]
Outstanding Options, Weighted-Average Exercise Price, granted
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
Financial Instrument
Financial Instrument [Axis]
Operating lease landlord agreed to contribution amount, approximate
Operating Lease Landlord Agreed To Contribution Amount
Operating lease landlord agreed to contribution amount.
Performance-based stock option activity, remaining contractual term
Outstanding Options, Weighted-Average Remaining Contractual Term (in years)
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
Merck & Co., Inc.
Merck Co Inc [Member]
Merck & co., Inc.
Restricted Cash and Investments, Noncurrent, Total
Restricted cash, included in other long-term assets
Restricted Cash And Investments Noncurrent
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Market development fees received.
Market Development Fees Received
Market development fees received
Expected number of employees affect in workforce reduction
Restructuring and Related Cost, Expected Number of Positions Eliminated
Contingencies Disclosure [Text Block]
Contingencies
Proceeds from issuance of warrants
Debt Securities, Available-for-Sale, Total
Debt securities, fair value
Investments, Fair Value
Available For Sale Securities Debt Securities
Accounting Policies [Abstract]
Raw materials
Inventory Raw Materials Net Of Reserves
Stockholders’ equity
Stockholders Equity [Abstract]
Exercise of Tempus Warrants
Stock Issued During Period Value Warrants Exercised
Stock issued during period value warrants exercised.
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total
Effect of exchange rates on cash, cash equivalents and restricted cash
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
Statement [Table]
Statement [Table]
Preferred stock, shares authorized
Preferred Stock Shares Authorized
Number of equal payments
Number Of Equal Payments
Number of equal payments.
Entity File Number
Securities Act File Number
Net change in cash, cash equivalents and restricted cash
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
Revenue From Contract With Customer [Abstract]
Earnings Per Share [Abstract]
Expected term (in years)
Warrants and Rights Outstanding, Term
Statement of Financial Position [Abstract]
Interest Expense, Total
Interest expense
Interest Expense, Operating and Nonoperating
Loss from operations
Operating Income Loss
Volatility
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
Accrued taxes
Accrued Income Taxes Current
Entity Shell Company
Entity Shell Company
Schedule of Risk-free Interest Rate Based on U.S. Treasury Yield Curve Over Expected Term of Warrants
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
Entity Tax Identification Number
Entity Tax Identification Number
Assets
Assets [Abstract]
Reclassification of adjustments to net loss due to dissolution of Personalis (Shanghai) Ltd
Reclassification of adjustments to net loss due to dissolution of Personalis (Shanghai) Ltd
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax
Class of Warrant or Right [Domain]
CHINA
Entity Current Reporting Status
Entity Current Reporting Status
Second milestone fees payable subject to achieving two additial clinical validations
Second Milestone Fees Payable Subject to Achieving Two Additial Clinical Validations
ATM facility
At-The-Market Facility [Member]
At-the-market facility.
Long-Term Debt, Type
Longterm Debt Type [Axis]
Contract liabilities
Increase Decrease In Contract With Customer Liability
Geographical
Segment Geographical [Domain]
Document Fiscal Year Focus
Document Fiscal Year Focus
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total
Outstanding Options, Number of Shares, forfeited or expired
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
Proceeds from sale of common stock under Tempus Investment Agreement
Proceeds from sale of common stock under Tempus Investment Agreement
Proceeds from sale of common stock under Tempus Investment Agreement
Cash, cash equivalents and restricted cash, beginning of period
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total
Total cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, end of period
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
City Area Code
City Area Code
Enterprise sales.
Enterprise Sales [Member]
Enterprise Sales
Warrants measurement input
Warrants and Rights Outstanding, Measurement Input
Current liabilities
Total current liabilities
Liabilities Current
Market Development Fees received from Tempus
Market Development Fees received from Tempus
Market Development Fees received from Tempus (Note 8)
Payment of costs related to Tempus Investment Agreement
Payment of costs related to Tempus Investment Agreement
Payment of costs related to Tempus Investment Agreement
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Local Phone Number
Local Phone Number
Lease impairment
Noncash lease impairment expense
Operating Lease, Impairment Loss
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Debt Disclosure [Line Items]
Debt Disclosure [Line Items]
Debt disclosure.
Proceeds from exercise of Tempus Warrants
Proceeds from Warrant Exercises
Outstanding stock options and awards (in shares)
Shares Subject To Options And Restricted Stock Or R S U Awards
Shares subject to options and restricted Stock or Rsu awards.
Outstanding stock awards
ESPP
Employee Stock Purchase Plan [Member]
Employee stock purchase plan.
Debt securities, aggregate cost basis
Investments, Adjusted Cost
Available For Sale Debt Securities Amortized Cost Basis
Less: current portion of operating lease liability
Operating lease liabilities
Operating Lease Liability Current
Net changes in foreign currency translation adjustments
Net changes in foreign currency translation adjustments
Foreign currency translation adjustment
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
Other.
Other [Member]
Other
Accumulated Deficit
Retained Earnings [Member]
Payments to Acquire Property, Plant, and Equipment, Total
Purchases of property and equipment
Payments To Acquire Property Plant And Equipment
Document Transition Report
Document Transition Report
2026
Lessee Operating Lease Liability Payments Due Year Two
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Outstanding Options, Weighted-Average Exercise Price, exercised
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
Minimum
Minimum [Member]
Common Stock
Common Stock [Member]
Unvested Restricted Stock Units, Weighted-Average Grant Date Fair Value, Beginning Balance
Unvested Restricted Stock Units, Weighted-Average Grant Date Fair Value, Ending Balance
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
Additional Paid-In Capital
Additional Paid In Capital [Member]
Adjustments to reconcile net loss to net cash used in operating activities
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]
Short-term Investments
Short Term Investments [Member]
Income Statement Location
Statement of Income Location, Balance [Domain]
2025
Lessee Operating Lease Liability Payments Due Next Twelve Months
July 2021
Tranche One [Member]
Tranche one.
Other long-term assets
Other Assets Noncurrent
September 2023
Tranche Five [Member]
Tranche five.
Entity Common Stock, Shares Outstanding
Entity Common Stock Shares Outstanding
Repayments of payment agreements with financing entity.
Repayments Of Payment Agreements With Financing Entity
Repayments of loans
Accrued and other current liabilities
Increase Decrease In Accrued Liabilities And Other Operating Liabilities
Disaggregation Of Revenue [Line Items]
Disaggregation Of Revenue [Line Items]
Lease Expiration Year
Lease Expiration Year
Lease expiration year.
Basis of Presentation
Basis Of Accounting Policy Policy [Text Block]
Concentration of Credit Risk and Other Risks and Uncertainties
Concentration Of Credit Risk And Other Risks And Uncertainties Policy Policy [Text Block]
Concentration of credit risk and other risks and uncertainties policy.
Warrants and rights outstanding
Warrants and Rights Outstanding
Noninterest bearing rate
Debt Instrument Noninterest Bearing Rate
Debt instrument noninterest bearing rate.
Pfizer Inc.
Pfizer Inc [Member]
Pfizer Inc.
Interest income
Investment Income Interest
Cash and cash equivalents, Fair Value
Cash And Cash Equivalents Fair Value Disclosure
Revenue
Revenue From Contract With Customer [Member]
Assets, Unrealized Losses
Assets Gross Unrealized Losses
Assets, gross unrealized losses.
Present value of future minimum lease payments
Operating Lease Liability
Measurement Frequency
Fair Value By Measurement Frequency [Axis]
Commitments And Contingencies
Commitments and contingencies
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Weighted Average Number of Shares Outstanding, Diluted, Total
Weighted-average common shares outstanding-diluted
Weighted-average shares outstanding, diluted
Weighted Average Number Of Diluted Shares Outstanding
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Accounts receivable, net
Accounts receivable, net
Accounts Receivable, after Allowance for Credit Loss, Current, Total
Accounts receivable, net
Accounts Receivable Net Current
Pharma tests and services.
Pharma Tests and Services [Member]
Pharma Tests and Services
Operating lease option to extend term
Lessee Operating Lease Renewal Term
Total future minimum lease payments
Lessee Operating Lease Liability Payments Due
Other Deferred Costs, Net, Total
Other deferred costs
Other Deferred Costs Net
Concentration Risk Benchmark
Concentration Risk Benchmark [Domain]
Warrant expiration date
Warrants and Rights Outstanding, Maturity Date
Number of Employees Eligible for Separation Pay
Number of Employees Eligible for Separation Pay
Number of employees eligible for separation pay
Entity Small Business
Entity Small Business
Loans
Debt Disclosure [Text Block]
Common stock shares purchased
Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award
U.S. Government Securities
U S Treasury Securities [Member]
Activation fees
Activation Fees
Activation fees
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total
Restricted stock units vested, shares
Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
Cash flows from financing activities:
Net Cash Provided By Used In Financing Activities [Abstract]
Performance-based stock option activity, exercise price
Outstanding Options, Weighted-Average Exercise Price, Beginning Balance
Outstanding Options, Weighted-Average Exercise Price, Ending Balance
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
Investment Agreement
Investment Agreement [Member]
Investment Agreement.
Fair value determined at settlement as the fair value of shares delivered
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Impact of Changes in Fair Value of Shares on Number of Shares
Asset Class
Fair Value By Asset Class [Axis]
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Right-of-use asset obtained in exchange for operating lease liability
Measurement Frequency
Fair Value Measurement Frequency [Domain]
Cash and cash equivalents, Unrealized Losses
Cash And Cash Equivalents Gross Unrealized Losses
Cash and cash equivalents, gross unrealized losses.
Level 3
Fair Value Inputs Level3
Fair Value, Inputs, Level 3 [Member]
Operating leases, weighted-average remaining lease term
Operating Lease Weighted Average Remaining Lease Term1
Amount payable
Accounts Payable, Current, Total
Accounts payable
Accounts Payable Current
Total costs and expenses
Costs And Expenses
Percentage of common stock owned
Percentage of Common Stock Owned
Percentage of common stock owned.
Short-term lease cost
Short Term Lease Cost